Latest News

Date Title Topic
23 Oct 2015 MAP 2015 Press Release: Genomic Alterations Could Lead to a Brave New World for Cancer Treatment
21 Oct 2015 Drug Repurposing in Oncology Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
20 Oct 2015 BRAF & NRAS in Melanoma Factsheets
14 Oct 2015 FDA Approves Expanded Indication for Medical Device to Treat Glioblastoma Multiforme Central nervous system malignancies
13 Oct 2015 FDA Expands Approved Use of Nivolumab in Advanced Lung Cancer Lung and other thoracic tumours - Immuno-oncology
12 Oct 2015 The Nobel Prize in Chemistry 2015 for Mechanistic Studies of DNA Repair Basic science
09 Oct 2015 European Medicines Agency Recommends Granting Marketing Authorisation for Cinacalcet Mylan Endocrine cancers
08 Oct 2015 European Medicines Agency Adopts a New Indication for Azacitidine Cancer in Special Situations - Haematologic malignancies - Anticancer agents & Biologic therapy
07 Oct 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Carfilzomib Haematologic malignancies - Anticancer agents & Biologic therapy
07 Oct 2015 EMA Recommends Granting a Marketing Authorisation for Blinatumomab Haematologic malignancies - Immuno-oncology
06 Oct 2015 FDA Approves Pembrolizumab for Advanced Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Immuno-oncology
05 Oct 2015 FDA Approves New Oral Medication to Treat Patients With Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
Travel Grants
30 Sep 2015 ESMO Video Commentary: Nivolumab Benefit Continues in NSCLC Lung and other thoracic tumours - Immuno-oncology
29 Sep 2015 ESMO Commentary: New Promising Options are Available for Renal Cell Carcinoma Genitourinary cancers - Immuno-oncology - Anticancer agents & Biologic therapy